DOP2010000135A - Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 - Google Patents
Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465Info
- Publication number
- DOP2010000135A DOP2010000135A DO2010000135A DO2010000135A DOP2010000135A DO P2010000135 A DOP2010000135 A DO P2010000135A DO 2010000135 A DO2010000135 A DO 2010000135A DO 2010000135 A DO2010000135 A DO 2010000135A DO P2010000135 A DOP2010000135 A DO P2010000135A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- tert
- butilpirazol
- adamantilcarbamoil
- benzoico
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
El acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-l-il]benzoico y sales farmaceuticamente aceptables de este y una forma cristalina particular del Agente (Forma 1); tambien se describen su use en la inhibicion de la 11BHSD1, procesos para fabricarlos y composiciones farmaceuticas que los comprenden.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98573507P | 2007-11-06 | 2007-11-06 | |
PK10808 | 2008-02-04 | ||
PCT/GB2008/000454 WO2008099145A1 (en) | 2007-02-12 | 2008-02-11 | Pyrazole derivatives as 11-beta-hsd1 inhibitors |
US8230408P | 2008-07-21 | 2008-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2010000135A true DOP2010000135A (es) | 2010-06-30 |
Family
ID=42759138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2010000135A DOP2010000135A (es) | 2007-11-06 | 2010-05-06 | Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 |
Country Status (17)
Country | Link |
---|---|
US (1) | US20110060022A1 (es) |
EP (1) | EP2217232A1 (es) |
JP (1) | JP2011502978A (es) |
KR (1) | KR20100095439A (es) |
CN (1) | CN101909621A (es) |
AU (1) | AU2008326226B2 (es) |
BR (1) | BRPI0819177A2 (es) |
CA (1) | CA2703781A1 (es) |
CO (1) | CO6270318A2 (es) |
CR (1) | CR11415A (es) |
DO (1) | DOP2010000135A (es) |
EA (1) | EA201000701A1 (es) |
EC (1) | ECSP10010159A (es) |
IL (1) | IL205455A0 (es) |
MX (1) | MX2010005048A (es) |
WO (1) | WO2009060232A1 (es) |
ZA (1) | ZA201003031B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006316087B2 (en) | 2005-11-21 | 2011-03-10 | Shionogi & Co., Ltd. | Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I |
TW200827346A (en) | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
TW200836719A (en) * | 2007-02-12 | 2008-09-16 | Astrazeneca Ab | Chemical compounds |
BRPI0811191A2 (pt) | 2007-05-18 | 2014-10-29 | Shionogi & Co | Derivado heterocíclico contendo nitrogênio tendo atividade inibitória para 11beta-hidroxiesteroide deidrogenase tipo 1 |
KR20100126306A (ko) * | 2008-02-04 | 2010-12-01 | 아스트라제네카 아베 | 4-[4-(2-(아다만틸카르바모일)-5-tert-부틸-피라졸-1-일]벤조산의 신규한 결정형 |
CA2719936A1 (en) * | 2008-04-22 | 2009-10-29 | Astrazeneca Ab | Substituted pyrimidin-5-carboxamides 281 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005528395A (ja) | 2002-04-05 | 2005-09-22 | ザ ユニバーシティ オブ エディンバラ | 組成物 |
EP1615698B1 (en) * | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
WO2006132436A1 (ja) * | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | 複素環化合物 |
-
2008
- 2008-11-05 US US12/741,589 patent/US20110060022A1/en not_active Abandoned
- 2008-11-05 CA CA2703781A patent/CA2703781A1/en not_active Abandoned
- 2008-11-05 EA EA201000701A patent/EA201000701A1/ru unknown
- 2008-11-05 AU AU2008326226A patent/AU2008326226B2/en not_active Ceased
- 2008-11-05 CN CN2008801245920A patent/CN101909621A/zh active Pending
- 2008-11-05 WO PCT/GB2008/051029 patent/WO2009060232A1/en active Application Filing
- 2008-11-05 KR KR1020107012380A patent/KR20100095439A/ko not_active Application Discontinuation
- 2008-11-05 JP JP2010531592A patent/JP2011502978A/ja not_active Withdrawn
- 2008-11-05 BR BRPI0819177 patent/BRPI0819177A2/pt not_active IP Right Cessation
- 2008-11-05 MX MX2010005048A patent/MX2010005048A/es not_active Application Discontinuation
- 2008-11-05 EP EP08847893A patent/EP2217232A1/en not_active Withdrawn
-
2010
- 2010-04-29 IL IL205455A patent/IL205455A0/en unknown
- 2010-04-30 ZA ZA2010/03031A patent/ZA201003031B/en unknown
- 2010-05-06 CR CR11415A patent/CR11415A/es not_active Application Discontinuation
- 2010-05-06 CO CO10054276A patent/CO6270318A2/es not_active Application Discontinuation
- 2010-05-06 DO DO2010000135A patent/DOP2010000135A/es unknown
- 2010-05-06 EC EC2010010159A patent/ECSP10010159A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP10010159A (es) | 2010-06-29 |
JP2011502978A (ja) | 2011-01-27 |
CO6270318A2 (es) | 2011-04-20 |
MX2010005048A (es) | 2010-07-28 |
KR20100095439A (ko) | 2010-08-30 |
CR11415A (es) | 2010-08-27 |
CA2703781A1 (en) | 2009-05-14 |
WO2009060232A1 (en) | 2009-05-14 |
CN101909621A (zh) | 2010-12-08 |
BRPI0819177A2 (pt) | 2015-05-05 |
EP2217232A1 (en) | 2010-08-18 |
ZA201003031B (en) | 2011-10-26 |
EA201000701A1 (ru) | 2010-12-30 |
AU2008326226B2 (en) | 2011-10-20 |
IL205455A0 (en) | 2010-12-30 |
AU2008326226A1 (en) | 2009-05-14 |
US20110060022A1 (en) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2010000135A (es) | Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 | |
AR124134A2 (es) | Formulación de uso tópico para un inhibidor de jak | |
DOP2010000323A (es) | Pirimidin-5-carboxamidas sustituidas 281 | |
PE20131464A1 (es) | Derivados de quinazolin-4 (3h)-ona utilizados como inhibidores de pi3 cinasa | |
MX2010008583A (es) | Novedosos formas cristalinas de acido 4-[4-(2-adamantilcarbamoil)- 5-ter-butil-pirazol-1-il]benzoico. | |
CR9832A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
CR20120058A (es) | Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina | |
AR057181A1 (es) | Nueva forma de dosificacion de combinacion | |
CR9703A (es) | Derivados de pirazolona | |
CL2009000914A1 (es) | Compuestos derivados de 1-ciano-3-pirrolidinil-n-sustituidas-sulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica. | |
CR20110219A (es) | Ácidos naftilacéticos | |
DOP2012000264A (es) | Formulacion farmaceutica en forma de comprimidos de dos capas que comprenden inhibidor de hmg-coa reductasa e irbesartan | |
PE20121467A1 (es) | Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica | |
CL2008001817A1 (es) | Sales piperazina, benzatina y colina en forma cristalina del acido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il)acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. | |
AR079945A1 (es) | Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3) | |
CO6321285A2 (es) | Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
UY32299A (es) | Composiciones farmacéuticas líquidas | |
RS54420B1 (en) | FORMULATION CONTAINING PHENYLAMINOPYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT | |
CU20100088A7 (es) | Ácido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 | |
NI201000080A (es) | Ácido 4 - [ 4 - (2 - adamantilcarbamoil) - 5 - tert - butilpirazol - 1 - il] benzoico - 465. | |
PE20070012A1 (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil) ftalazin-1-ilo] micronizado, y sus sales | |
ECSP11011212A (es) | Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido | |
AR084435A1 (es) | Combinacion y composicion para el tratamiento de obesidad | |
CO6331424A2 (es) | Formulacion farmaceutica de eprosartan |